Fred Alger Management, LLC Immunocore Holdings PLC Transaction History

Fred Alger Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$60.14 - $75.36 $196,778 - $246,577	3,272 Added 52.71%	9,479 $616,000
Q4 2023 Feb 14, 2024	BUY	$42.85 - $69.5 $85,785 - $139,139	2,002 Added 47.61%	6,207 $424,000
Q3 2023 Nov 14, 2023	SELL	$49.5 - $66.6 $116,770 - $157,109	-2,359 Reduced 35.94%	4,205 $218,000
Q2 2023 Aug 14, 2023	BUY	$48.54 - $61.64 $73,635 - $93,507	1,517 Added 30.06%	6,564 $393,000
Q1 2023 May 15, 2023	SELL	$46.12 - $65.71 $152,749 - $217,631	-3,312 Reduced 39.62%	5,047 $249,000
Q4 2022 Feb 14, 2023	BUY	$45.51 - $65.08 $17,384 - $24,860	382 Added 4.79%	8,359 $477,000
Q3 2022 Nov 14, 2022	BUY	$37.34 - $57.44 $297,861 - $458,198	7,977 New	7,977 $374,000

141

41.4M

197K

451K

Ticker IMCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,897,100
Market Cap $1.24B
Description
Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fred Alger Management, LLC with notifications on news.